Dillard's, Inc. (DDS)
Official siteCONSUMER CYCLICAL • DEPARTMENT STORES • NYSE
Market Cap: $9.11B
Last updated: Nov 17, 2026 at 4:33 PM ET
Dillard's, Inc. (DDS) Statistics
Dillard's (DDS) has a market cap of $9.11B and an enterprise value of $8.77B. Its trailing P/E of 14.7x is above its 10-year median of 11.1x.
Total Valuation
Enterprise value is 3.70% below the market cap, as cash exceeds debt.
| Market Cap | $9.11B |
|---|---|
| Enterprise Value | $8.77B |
| Latest price (Nov 17, 2026) | $554.24 |
Key Dates
The last ex-dividend date was Sep 30, 2026.
| Last Earnings Date | Nov 12, 2026 |
|---|---|
| Last Ex-Dividend Date | Sep 30, 2026 |
| Last Payment Date | Nov 2, 2026 |
| Fiscal Year End | January |
Valuation Ratios
Sales and book value multiples are 1.3x and 4.1x. Its year-end P/E ranged from 6.6x to 16.8x from 2016 to 2025.
| P/E Ratio | 14.7x |
|---|---|
| Forward P/E | 13.3x |
| P/S Ratio | 1.3x |
| Forward P/S | 1.4x |
| P/B Ratio | 4.1x |
| P/FCF Ratio | 13.6x |
| P/OCF Ratio | 12.6x |
Enterprise Valuation
Counting debt and cash, the company is valued at 8.2x EBITDA and 13.1x free cash flow.
| EV / Earnings | 12.9x |
|---|---|
| EV / Sales | 1.3x |
| EV / EBITDA | 8.2x |
| EV / FCF | 13.1x |
Price Statistics
The stock is down 8.77% over 52 weeks and trades 14.38% below its 50-day average.
| Beta (1Y) | 0.70 |
|---|---|
| 52-Week Change | -8.77% |
| 1-Month Change | -16.86% |
| 3-Month Change | -9.97% |
| 6-Month Change | +4.48% |
| 5-Year Change | +177.42% |
| 10-Year Change | +946.07% |
| Total Return (1Y) | -3.63% |
| Total Return (3Y CAGR) | +22.32% |
| Total Return (5Y CAGR) | +13.13% |
| Return vs SPY (1Y) | -14.87% |
| Max Drawdown (1Y) | -27.11% |
| Max Drawdown (3Y) | -42.02% |
| Sharpe Ratio (1Y) | -0.08 |
| Correlation with SPY (1Y) | 0.23 |
| 50-Day Average | $647.36 |
| 200-Day Average | $604.17 |
| 52-Week Range | $502.84 to $727.12 |
| RSI (14 Days) | 35.5 |
| Average Volume (20 Days) | 125.54K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.03x current liabilities, and total debt is 0.20x shareholder equity.
| Current Ratio | 3.03x |
|---|---|
| Quick Ratio | 1.58x |
| Debt / Equity | 0.20x |
| Debt / EBITDA | 0.42x |
| Debt / FCF | 0.67x |
| Interest Coverage | -112.18x |
Returns and Efficiency
Return on invested capital is 26.50% over the last 12 months, against a 5-year average of 31.81%.
| Return on Equity (ROE) | 32.15% |
|---|---|
| Return on Assets (ROA) | 18.18% |
| Return on Invested Capital (ROIC) | 26.50% |
| ROE (5Y Average) | 44.77% |
| ROA (5Y Average) | 21.57% |
| ROIC (5Y Average) | 31.81% |
| Asset Turnover | 1.77x |
| Inventory Turnover | 2.79x |
| Receivables Turnover | 142.66x |
| Cash Conversion Cycle | 45 days |
Taxes
Income tax took 18.99% of pretax income over the last 12 months.
| Income Tax (TTM) | $159.61M |
|---|---|
| Effective Tax Rate | 18.99% |
Scores
DDS has an Altman Z-Score of 8.74, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 8.74 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $6.60B over the last 12 months is up 0.07% from the 12 months before.
| Revenue | $6.60B |
|---|---|
| Revenue Growth (YoY) | +0.07% |
| Gross Profit | $2.70B |
| Operating Income | $853.02M |
| Pretax Income | $840.37M |
| Net Income | $681.77M |
| EBITDA | $1.01B |
| Reported EPS (TTM) | $37.74 |
Trailing 12 months through Jul 31, 2026.
Balance Sheet
Shareholder equity funds 56.53% of the $3.75B in total assets.
| Cash and Equivalents | $763.08M |
|---|---|
| Total Debt | $425.73M |
| Net Cash | $337.35M |
| Net Cash Per Share | $21.60 |
| Working Capital | $1.80B |
| Shareholder Equity | $2.12B |
| Book Value Per Share | $135.77 |
| Total Assets | $3.75B |
| Total Liabilities | $1.63B |
Balance sheet as of Jul 31, 2026.
Cash Flow
After $89.34M of capital spending, operating cash flow left $635.08M of free cash flow.
| Operating Cash Flow | $724.41M |
|---|---|
| Capital Expenditures | $89.34M |
| Free Cash Flow | $635.08M |
| FCF Per Share | $53.55 |
| Depreciation and Amortization | $179.41M |
| Dividends Paid | $486.35M |
Trailing 12 months through Jul 31, 2026.
Margins
The operating margin is 12.93%, against a 5-year average of 13.86%.
| Gross Margin | 40.97% |
|---|---|
| Operating Margin | 12.93% |
| Pretax Margin | 12.74% |
| Net Margin | 10.34% |
| EBITDA Margin | 15.35% |
| FCF Margin | 9.63% |
| Gross Margin (5Y Average) | 41.44% |
| Operating Margin (5Y Average) | 13.86% |
| Net Margin (5Y Average) | 10.85% |
Growth
Revenue fell 2.11% a year over 3 years, and EPS 10.34% a year.
| Revenue Growth (3Y CAGR) | -2.11% |
|---|---|
| Revenue Growth (5Y CAGR) | +8.16% |
| EPS Growth (3Y CAGR) | -10.34% |
| FCF Growth (3Y CAGR) | -9.03% |
| FCF Growth (5Y CAGR) | +26.50% |
| Operating Income Growth (3Y CAGR) | -14.83% |
| Book Value Per Share Growth (2Y CAGR) | +4.33% |
| Tangible Book Per Share Growth (2Y CAGR) | +4.33% |
Dividends and Yields
DDS pays out 2.75% of earnings as dividends.
| Dividend Per Share (Annual) | $1.20 |
|---|---|
| Dividend Yield | 0.22% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +11.20% |
| Dividend Growth (5Y CAGR) | +12.89% |
| Payout Ratio | 2.75% |
| FCF Payout Ratio | 76.58% |
| Earnings Yield | 6.80% |
| FCF Yield | 7.34% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 5.62% |
Peer Position
Against 11 similar companies, DDS has the 8th highest P/E.
P/E RatioPeer median 16.8x
P/S RatioPeer median 1.1x
ROICPeer median 21.12%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +6.07%
Dividend YieldPeer median 0.27%
| P/E Ratio | 14.7x vs 16.8x median |
|---|---|
| P/S Ratio | 1.3x vs 1.1x median |
| ROIC | 26.50% vs 21.12% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +0.07% vs +6.07% median |
| Dividend Yield | 0.22% vs 0.27% median |
Analyst Forecast
Consensus estimates put revenue growth at 0.79% and EPS growth at -1.10% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +0.79% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -1.10% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DDS
What is DDS's market cap?
Dillard's has a market cap of $9.11B. Its enterprise value, which adds debt and subtracts cash, is $8.77B.
What is DDS's P/E ratio?
Dillard's has a trailing P/E ratio of 14.7x and a forward P/E of 13.3x.
How many shares of DDS are outstanding?
Dillard's has 15.62M shares outstanding. The count is up 0.04% from a year earlier.
Does DDS pay a dividend?
Yes. Dillard's pays $1.20 a share a year, a dividend yield of 0.22%.
How much debt does DDS have?
Dillard's has $425.73M of total debt and $763.08M of cash and equivalents, a net cash position of $337.35M.
DDS pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors